glycyl-arginyl-glycyl-aspartyl-serine has been researched along with glycyl-prolyl-arginyl-proline in 1 studies
| Studies (glycyl-arginyl-glycyl-aspartyl-serine) | Trials (glycyl-arginyl-glycyl-aspartyl-serine) | Recent Studies (post-2010) (glycyl-arginyl-glycyl-aspartyl-serine) | Studies (glycyl-prolyl-arginyl-proline) | Trials (glycyl-prolyl-arginyl-proline) | Recent Studies (post-2010) (glycyl-prolyl-arginyl-proline) |
|---|---|---|---|---|---|
| 190 | 0 | 42 | 57 | 0 | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adelman, B; Gennings, C; Hanners, E; Strony, J | 1 |
1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-serine and glycyl-prolyl-arginyl-proline
| Article | Year |
|---|---|
Synergistic inhibition of platelet aggregation by fibrinogen-related peptides.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Drug Synergism; Fibrinogen; Humans; Molecular Sequence Data; Oligopeptides; Peptide Fragments; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors | 1990 |